Research News

The exhibit “Serenades for Settling: Tending Ostreidae” with several large screens of ocean life in a darkened room.
  • Listen like an oyster
    12/12/25

    An immersive, multimedia exhibition invites audiences into an underwater world of oysters, and how human-made sounds might affect them. 

  • Bling, bling!
    10/23/14

    UB chemist Jason Benedict has organized a crystal-growing challenge for K-12 students — and the "biggest, nicest” crystals win.

  • More companies join START-UP NY at UB
    10/23/14

    Five more companies will set up shop on or near the UB campuses under START-UP NY, the innovative tax-incentive program created by Gov. Andrew M. Cuomo.

  • Reducing hazmat risk
    10/20/14

    UB researcher Changhyun Kwon has received a NSF CAREER Award to build a routing simulator that would reduce catastrophic hazardous materials accidents.

  • Architect Barbie, three years later
    10/16/14

    Architect Barbie co-creaters Despina Stratigakos and Kelly Hayes McAlonie are traveling to Washington, D.C., to talk about how the gender debate in the profession has changed.

  • Continuing HIV drug development
    10/16/14

    The School of Pharmacy and Pharmaceutical Sciences has received three grants totaling $3.85 million from the National Institutes of Health for the Translational Pharmacology Research Core and its HIV Clinical Pharmacology Research Program.

  • RENEW awards seed funding
    10/16/14

    Four research projects have received seed funding under RENEW, UB’s new interdisciplinary environmental research initiative.

  • Transforming patient care
    10/16/14

    In response to new 'game-changing' hepatitis C treatments, UB has launched a clinical care center to advance research, clinical management and education on liver disease.

  • Food (policy) back on the table
    10/16/14

    A new UB study outlines seven factors that led one of America’s poorest cities to embrace farming, urban chickens and more

  • Extending battery life
    10/13/14

    Three UB research groups have received a combined $1.3 million in federal grants to improve smartphone energy management.

  • Rights acquired to spider-venom drug
    10/9/14

    A clinical-stage biopharmaceutical company has acquired the rights to a drug that UB scientists have begun developing for Duchenne muscular dystrophy, a common, fatal genetic disease affecting young boys.